Tahaineh L, Edaily SM, & Gharaibeh SF. (2018). Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications. Dove Medical Press.
Chicago Style (17th ed.) CitationTahaineh L, Edaily SM, and Gharaibeh SF. Anti-factor Xa Levels in Obese Patients Receiving Enoxaparin for Treatment and Prophylaxis Indications. Dove Medical Press, 2018.
MLA (9th ed.) CitationTahaineh L, et al. Anti-factor Xa Levels in Obese Patients Receiving Enoxaparin for Treatment and Prophylaxis Indications. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.